Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reineke A Schoot

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
The Cochrane Database of Systematic Reviews|June 27, 2013
Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancerReineke A Schoot, Elvira C van Dalen, Cornelia H van Ommen, et al.
The Lancet. Oncology|November 4, 2022
Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPEMaria Otth, Eva Brack, Pamela R Kearns, et al.
The Cochrane Database of Systematic Reviews|September 13, 2013
Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous cathetersReineke A Schoot, Leontien C M Kremer, Marianne D van de Wetering, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2022
Market access to new anticancer medicines for children and adolescents with cancer in EuropeReineke A Schoot, Maria A Otth, Gerardus W J Frederix, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2013
The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastomaReineke A Schoot, Gitta Bleeker, Huib N Caron, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2013
Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysisGitta Bleeker, Reineke A Schoot, Huib N Caron, et al.
Radiology|August 30, 2013
Response assessment in pediatric rhabdomyosarcoma: can response evaluation criteria in solid tumors replace three-dimensional volume assessments?Reineke A Schoot, Kieran McHugh, Rick R van Rijn, et al.
Tumori|November 10, 2025
Trabectedin-irinotecan as a potential therapeutic option in desmoplastic small round cell tumor: A small case seriesAndrea Ferrari, Stefano Chiaravalli, Walter Ferrari Bravo, et al.
Pediatric Radiology|April 26, 2024
Bone marrow disease in rhabdomyosarcoma visualized by 2-[<sup>18</sup>F]fluorodeoxyglucose positron emission tomography/computed tomographyPia Kröning, Sebastian Berg, Martin T Freitag, et al.
Insights Into Imaging|January 31, 2023
Methodological considerations on segmenting rhabdomyosarcoma with diffusion-weighted imaging-What can we do better?Cyrano Chatziantoniou, Reineke A Schoot, Roelof van Ewijk, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
The Cochrane Database of Systematic Reviews|June 27, 2013
Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancerReineke A Schoot, Elvira C van Dalen, Cornelia H van Ommen, et al.
The Lancet. Oncology|November 4, 2022
Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPEMaria Otth, Eva Brack, Pamela R Kearns, et al.
The Cochrane Database of Systematic Reviews|September 13, 2013
Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous cathetersReineke A Schoot, Leontien C M Kremer, Marianne D van de Wetering, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2022
Market access to new anticancer medicines for children and adolescents with cancer in EuropeReineke A Schoot, Maria A Otth, Gerardus W J Frederix, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2013
The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastomaReineke A Schoot, Gitta Bleeker, Huib N Caron, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2013
Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysisGitta Bleeker, Reineke A Schoot, Huib N Caron, et al.
Radiology|August 30, 2013
Response assessment in pediatric rhabdomyosarcoma: can response evaluation criteria in solid tumors replace three-dimensional volume assessments?Reineke A Schoot, Kieran McHugh, Rick R van Rijn, et al.
Tumori|November 10, 2025
Trabectedin-irinotecan as a potential therapeutic option in desmoplastic small round cell tumor: A small case seriesAndrea Ferrari, Stefano Chiaravalli, Walter Ferrari Bravo, et al.
Pediatric Radiology|April 26, 2024
Bone marrow disease in rhabdomyosarcoma visualized by 2-[<sup>18</sup>F]fluorodeoxyglucose positron emission tomography/computed tomographyPia Kröning, Sebastian Berg, Martin T Freitag, et al.
Insights Into Imaging|January 31, 2023
Methodological considerations on segmenting rhabdomyosarcoma with diffusion-weighted imaging-What can we do better?Cyrano Chatziantoniou, Reineke A Schoot, Roelof van Ewijk, et al.
Pageof 5